Caribou Historical Cash Flow

CRBU Stock  USD 1.98  0.02  1.02%   
Analysis of Caribou Biosciences cash flow over time is an excellent tool to project Caribou Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 14.4 M or Begin Period Cash Flow of 88.3 M as it is a great indicator of Caribou Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Caribou Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Caribou Biosciences is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

About Caribou Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Caribou balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Caribou's non-liquid assets can be easily converted into cash.

Caribou Biosciences Cash Flow Chart

At this time, Caribou Biosciences' Stock Based Compensation is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 88.3 M in 2024, despite the fact that Change In Cash is likely to grow to (6.8 M).

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Caribou Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Caribou Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Caribou Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Caribou Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.At this time, Caribou Biosciences' Stock Based Compensation is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 88.3 M in 2024, despite the fact that Change In Cash is likely to grow to (6.8 M).

Caribou Biosciences cash flow statement Correlations

0.06-0.080.48-0.230.190.16-0.1-0.17-0.03-0.19-0.40.190.14-0.22-0.170.040.18-0.20.20.2
0.06-0.38-0.69-0.520.46-0.85-0.31-0.37-0.98-0.50.57-0.450.7-0.87-0.54-0.910.22-0.430.450.46
-0.08-0.380.01-0.270.380.72-0.74-0.120.54-0.16-0.79-0.360.130.74-0.280.710.02-0.390.430.45
0.48-0.690.010.65-0.640.50.340.60.630.66-0.370.83-0.770.360.690.54-0.430.62-0.62-0.62
-0.23-0.52-0.270.65-0.990.030.590.940.370.990.290.91-0.970.211.00.19-0.80.99-0.98-0.98
0.190.460.38-0.64-0.990.05-0.66-0.91-0.3-0.96-0.36-0.930.95-0.1-0.99-0.10.74-1.01.00.99
0.16-0.850.720.50.030.05-0.15-0.030.930.06-0.920.03-0.270.910.050.980.09-0.080.070.07
-0.1-0.31-0.740.340.59-0.66-0.150.310.130.450.440.58-0.58-0.10.61-0.09-0.130.65-0.71-0.74
-0.17-0.37-0.120.60.94-0.91-0.030.310.260.980.260.87-0.880.150.930.13-0.930.92-0.88-0.86
-0.03-0.980.540.630.37-0.30.930.130.260.38-0.710.31-0.580.930.390.97-0.140.28-0.28-0.29
-0.19-0.5-0.160.660.99-0.960.060.450.980.380.230.91-0.950.230.980.21-0.870.97-0.94-0.93
-0.40.57-0.79-0.370.29-0.36-0.920.440.26-0.710.230.18-0.06-0.730.26-0.84-0.260.38-0.39-0.39
0.19-0.45-0.360.830.91-0.930.030.580.870.310.910.18-0.910.050.930.14-0.720.92-0.92-0.91
0.140.70.13-0.77-0.970.95-0.27-0.58-0.88-0.58-0.95-0.06-0.91-0.4-0.98-0.410.72-0.940.940.93
-0.22-0.870.740.360.21-0.10.91-0.10.150.930.23-0.730.05-0.40.210.96-0.140.09-0.08-0.08
-0.17-0.54-0.280.691.0-0.990.050.610.930.390.980.260.93-0.980.210.2-0.780.99-0.98-0.98
0.04-0.910.710.540.19-0.10.98-0.090.130.970.21-0.840.14-0.410.960.2-0.060.08-0.08-0.08
0.180.220.02-0.43-0.80.740.09-0.13-0.93-0.14-0.87-0.26-0.720.72-0.14-0.78-0.06-0.770.720.68
-0.2-0.43-0.390.620.99-1.0-0.080.650.920.280.970.380.92-0.940.090.990.08-0.77-1.0-0.99
0.20.450.43-0.62-0.981.00.07-0.71-0.88-0.28-0.94-0.39-0.920.94-0.08-0.98-0.080.72-1.01.0
0.20.460.45-0.62-0.980.990.07-0.74-0.86-0.29-0.93-0.39-0.910.93-0.08-0.98-0.080.68-0.991.0
Click cells to compare fundamentals

Caribou Biosciences Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.